Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HH.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCEEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.12.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LZ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KW.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
KP.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.56.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.13.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDLEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.29.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.29.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.178EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.208EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.197EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.491EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.8 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BQ.1.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.75.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.347EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.195EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.321EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.379EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used